A growing body of real-world data shows efficacy of injectable treatments for pseudophakic cystoid macular edema, but evidence from well-designed large studies is lacking, according to a systematic ...

Please provide your email address to receive an email when new articles are posted on . A 72-year-old woman was referred to the uveitis clinic at the New England Eye Center for recurrent bilateral ...

Since February 2015, aflibercept (trade name Eylea) has been available also for patients with impaired vision due to macular oedema that follows blockage of branch veins of the central retinal vein ...

The treatment was approved in October 2021 and is the first FDA-approved therapy to treat macular edema associated with uveitis via injection to the suprachoroidal space, which provides a more ...

SUMMARY POINTS Uveitis is a major cause of visual impairment in people of working age Patients with suspected uveitis should have an assessment of visual acuity and a dilated slit lamp examination ...

The National Institute for Health and Care Excellence (NICE) has today published final draft guidance recommending a new treatment for people with diabetic macular oedema (DMO). DMO is the most common ...